AU5179293A - Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine - Google Patents

Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine

Info

Publication number
AU5179293A
AU5179293A AU51792/93A AU5179293A AU5179293A AU 5179293 A AU5179293 A AU 5179293A AU 51792/93 A AU51792/93 A AU 51792/93A AU 5179293 A AU5179293 A AU 5179293A AU 5179293 A AU5179293 A AU 5179293A
Authority
AU
Australia
Prior art keywords
bursal disease
infectious bursal
disease vaccine
recombinant infectious
herpesvirus vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51792/93A
Other languages
English (en)
Inventor
Jean-Christophe Francis Audonnet
Eliane Louise Francoise Laplace
Michel Emile Albert Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Publication of AU5179293A publication Critical patent/AU5179293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU51792/93A 1992-11-02 1993-10-11 Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine Abandoned AU5179293A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9213109A FR2697534A1 (fr) 1992-11-02 1992-11-02 Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
FR9213109 1992-11-02
PCT/FR1993/001002 WO1994010321A1 (fr) 1992-11-02 1993-10-11 Vecteur herpesviral de la dinde comme vaccin recombinant contre la maldie de gumboro

Publications (1)

Publication Number Publication Date
AU5179293A true AU5179293A (en) 1994-05-24

Family

ID=9435097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51792/93A Abandoned AU5179293A (en) 1992-11-02 1993-10-11 Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine

Country Status (3)

Country Link
AU (1) AU5179293A (fr)
FR (1) FR2697534A1 (fr)
WO (1) WO1994010321A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961982A (en) * 1985-09-06 1999-10-05 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
AU4489896A (en) * 1994-12-30 1996-07-24 Rhone Merieux Avian recombinant live vaccine
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02500409A (ja) * 1987-07-27 1990-02-15 シントロ・コーポレイシヨン 弱毒化ヘルペスウイルス、アミノ酸配列コード化外来dna含有ヘルペスウイルス並びに同上含有ワクチン
FR2659349B1 (fr) * 1990-03-12 1993-12-24 Rhone Merieux Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
BE1004877A3 (fr) * 1991-05-27 1993-02-16 Solvay Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.
CA2110505A1 (fr) * 1991-07-26 1993-02-18 Enzo Paoletti Vaccin poxvirus recombinant contre le virus de la bursite infectieuse

Also Published As

Publication number Publication date
FR2697534A1 (fr) 1994-05-06
WO1994010321A1 (fr) 1994-05-11

Similar Documents

Publication Publication Date Title
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU4071595A (en) Live recombinant avian vaccine using an avian herpesvirus as vector
ZA9711247B (en) Recombinant live avian vaccine using as vector the avian infectious laryngotracheitis virus
AU3448797A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
EP0708658A4 (fr) Vaccin contenant un cytomegalovirus de recombinaison
AU6769890A (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
AU4878096A (en) Hepatitis b vaccine
AU6304996A (en) Vaccines against hepatitis c
AU4450093A (en) Hepatitis A virus vaccine
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
IL101780A (en) Recombinant avipox virus a culture of cells infected with this virus vaccines for poultry derived from this virus use of the virus as a vector and a transfer sequence for insertion into the virus
EP0473210A3 (en) Recombinant marek's disease virus
AU5179293A (en) Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine
AU6698900A (en) Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
AU6358190A (en) Polypeptide vaccines against foot-and-mouth disease virus
PL328414A1 (en) Vaccines against a product of gene 63 of the varicell zoster virus
AU3509693A (en) A recombinant hepatitis C virus polypeptide
ZA956106B (en) A polynucleotide herpes virus vaccine
AU2961195A (en) Chicken infectious anemia virus vaccine
GB9201139D0 (en) Synthetic peptides for a rubella vaccine
ZA908189B (en) Infectious bronchitis virus vaccine
EP0598759A4 (fr) Virus recombinant de la rhino-tracheite infectieuse des bovins.
AU2347692A (en) Recombinant viral vaccine
HUT72921A (en) Marek's disease virus vaccine